bicuculline has been researched along with Alzheimer Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, J; Ehrhart, J; Giunta, B; Hou, H; Obregon, D; Sawmiller, D; Tan, J; Tian, J; Zhang, SQ | 1 |
| Kadoyama, K; Matsumoto, A; Matsuyama, S; Taniguchi, T | 1 |
| Baumann, D; Mueggler, T; Rausch, M; Rudin, M; Staufenbiel, M; Sturchler-Pierrat, C | 1 |
| Huang, J; Marszalec, W; Narahashi, T; Toth, PT; Yeh, JZ; Zhao, X | 1 |
| Greene, JR; Mudher, AK; Perry, VH; Woolley, ST | 1 |
| Dani, JA; Ji, D; Lape, R | 1 |
6 other study(ies) available for bicuculline and Alzheimer Disease
| Article | Year |
|---|---|
Baicalein reduces β-amyloid and promotes nonamyloidogenic amyloid precursor protein processing in an Alzheimer's disease transgenic mouse model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Antioxidants; Bicuculline; CHO Cells; Cricetulus; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Flavanones; GABA-A Receptor Antagonists; Gene Expression Regulation; Humans; Maze Learning; Mice; Mice, Transgenic; Mutation; Transfection | 2013 |
Long-term potentiation-like facilitation through GABAA receptor blockade in the mouse dentate gyrus in vivo.
Topics: Alzheimer Disease; Animals; Bicuculline; Dentate Gyrus; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; GABA Antagonists; Humans; Long-Term Potentiation; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Neurons; tau Proteins | 2008 |
Compromised hemodynamic response in amyloid precursor protein transgenic mice.
Topics: Acetazolamide; Age Factors; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Bicuculline; Body Weight; Brain; Carbonic Anhydrase Inhibitors; Cerebrovascular Circulation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance; GABA Antagonists; GABA-A Receptor Antagonists; Hemodynamics; Humans; Magnetic Resonance Imaging; Mice; Mice, Transgenic; Phenotype | 2002 |
In vitro galantamine-memantine co-application: mechanism of beneficial action.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Alzheimer Disease; Animals; Bicuculline; Calcium Signaling; Cells, Cultured; Cerebral Cortex; Cholinesterase Inhibitors; Corpus Striatum; Drug Evaluation, Preclinical; Drug Synergism; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Galantamine; Glycine; In Vitro Techniques; Inhibitory Concentration 50; Memantine; Nerve Tissue Proteins; Neuroprotective Agents; Nicotinic Agonists; Patch-Clamp Techniques; Perfusion; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, Nicotinic; Strychnine; Synaptic Transmission; Therapeutic Irrigation | 2006 |
Induction of hyperphosphorylated tau in living slices of rat hippocampal formation and subsequent detection using an ELISA.
Topics: Alzheimer Disease; Animals; Bicuculline; Brain Chemistry; Buffers; Electrophysiology; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; GABA Antagonists; Hippocampus; Ionophores; Male; Membrane Potentials; Okadaic Acid; Organ Culture Techniques; Phosphoprotein Phosphatases; Phosphorylation; Protein Kinase Inhibitors; Protein Kinases; Protein Phosphatase 1; Rats; Rats, Wistar; tau Proteins | 1999 |
Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Acetylcholine; alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Amino Acid Substitution; Animals; Bicuculline; Heterozygote; Hippocampus; Humans; In Vitro Techniques; Interneurons; Long-Term Potentiation; Mecamylamine; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Models, Animal; Neuronal Plasticity; Nicotinic Antagonists; Patch-Clamp Techniques; Point Mutation; Pyramidal Cells; Receptors, Nicotinic; Synapses | 2001 |